Correction to: Oncogene https://doi.org/10.1038/s41388-021-01941-z, published online 8 October 2021
Following the publication of this article an error was noted in Figure 4B. The authors inadvertently used incorrect images for the HCT116 cells. The updated version of Figure 4B (HCT116) is shown below. The authors confirm that the conclusions of the article are not affected by this correction and apologize for any inconvenience this may have caused. The original article has been corrected.
Former version:
Correct version:
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, J., Zhai, J., Wong, C.C. et al. Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML). Oncogene 44, 634–636 (2025). https://doi.org/10.1038/s41388-025-03304-4
Published:
Issue date:
DOI: https://doi.org/10.1038/s41388-025-03304-4
